does tirzepatide effect libido 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often What to Expect After Starting

Beyond GLP-1: The next wave of incretin-based obesity treatments GIP/GLP-1 dual agonists (e.g., #Tirzepatide) weight loss vs

Dosing protocols and timing for Canadians.

To stay ahead of this shifting environment, pharma companies should consider the following imperatives: Massive patient drop-off undermines obesity GLP-1 uptake: Despite strong demand, only 10% of obesity patients persist with therapy after one year

Conclusions These data demonstrate for the first time the potent effect of semaglutide in reducing voluntary alcohol intake in non-human primates and further substantiate the need for clinical trials investigating the effect of semaglutide in patients with alcohol-use disorder.